logo
Share SHARE
FONT-SIZE Plus   Neg

Insmed Names Will Lewis President, CEO, Effective Immediately - Quick Facts

Insmed Inc. (INSM) said it appointed Will Lewis as president and chief executive officer, or CEO, effective immediately. Lewis has also been appointed to the company's Board of Directors. Lewis succeeds Tim Whitten, who has resigned as president and CEO and as a member of Insmed's Board of Directors.

Lewis has above 20 years of executive experience and a track record of success in the pharmaceutical and finance industries both in the U.S. and internationally. He is the former co-founder, president and chief financial officer of Aegerion Pharmaceuticals, Inc. (AEGR). During his tenure at Aegerion, he played a pivotal role in re-orienting the company's strategy to focus on orphan disease indications enabling Aegerion to go public in one of the best performing IPOs of 2010. Before joining Aegerion, he spent more than 10 years working in the U.S. and Europe in investment banking for JP Morgan, Robertson Stephens and Wells Fargo.

In addition, Insmed noted that Donald Hayden, Jr., who was appointed as executive chairman in May 2012, will return to his role as chairman, effective immediately.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The recent week marked the lull before the storm, with very few market moving economic numbers released during the week. However, the economic news flow picks up pace in the upcoming week, offering glimpses into every vehicle of economic growth, ranging from consumers to private sector activity to housing.... Life expectancy at birth in the U.S. is already lower than most other developed nations and is now projected to fall further behind by 2030, according to a new study. It also suggests that by 2030, national female life expectancy in South Korea could break the 90 year barrier. Department store chain J.C. Penney Co. Inc. on Friday reported a turnaround to profit in the fourth quarter as a slight decline in sales was more than offset by lower expenses. Adjusted earnings per share for the quarter beat analysts' expectations, while revenues slightly missed their estimates. Earlier today, J.C. Penny announced a plan to optimize its national retail operations.
comments powered by Disqus
Follow RTT